Home > Healthcare > Medical Devices > Diagnostic Devices > Hematology Diagnostics Market

Hematology Diagnostics Market Size

Report ID: GMI5640
Published Date: May 2023
Report Format: PDF

Download Free Sample

Hematology Diagnostics Market Size

Hematology Diagnostics Market size was valued at around USD 3.8 billion in 2022 and is projected to register 4.7% CAGR between 2023 and 2032. Increasing prevalence of chronic conditions including blood and blood disorders along with technological advancements pertaining to hematology diagnostics is expected to foster the industry trends.

To get key market trends

Download Free Sample

The introduction of highly advanced haematology analysers, increasing utilisation of flow cytometry tests, and a surge in demand for the sophisticated point-of-care haematology analysers will aid in the overall business share. Additionally, factors such as the rising number of diagnostic laboratories, the growing aging population affected by chronic conditions, and increased patient awareness. Moreover, innovative strategies and collaboration is one of the main methods used by market participants to maintain competitiveness and have a diverse product portfolio.

Hematology diagnostics is intended for the diagnosis and treatment of diseases of the blood and blood-forming tissues. These tests help to evaluate the various components of the blood, such as red blood cells, white blood cells, and platelets, as well as the clotting factors and other proteins involved in blood function. Hematology diagnostics help to identify and diagnose various blood disorders, such as anemia, leukemia, lymphoma, clotting disorders, and other conditions affecting the blood and bone marrow.

Hematology Diagnostics Market Report Attributes
Report Attribute	Details
Base Year:	2022
Hematology Diagnostics Market Size in 2022:	USD 3.8 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	4.7%
2032 Value Projection:	USD 5.9 Billion
Historical Data for:	2018 to 2022
No. of Pages:	180
Tables, Charts & Figures:	364
Segments covered:	Product, Test Type, End-use, and Region
Growth Drivers:	Increasing prevalence of blood & related disorders Rising awareness regarding diagnosis of targeted diseases Technological advancements in hematology diagnostics Increasing adoption of point-of-care testing in developing countries
Pitfalls & Challenges:	High cost of hematology diagnostics Lack of reimbursement and inadequate insurance coverage

What are the growth opportunities in this market?

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for hematology diagnostics was USD 3.8 billion in 2022 and will reach over USD 5.9 billion by the end of 2032 due to the surging prevalence of chronic conditions, such as blood and blood disorders worldwide.

Instruments held over 62% of the hematology diagnostics market share in 2022 and will witness expansion through 2032 owing to increasing penetration in blood screening and diagnostics.

U.S. hematology diagnostics share is estimated to reach USD 2.1 billion by 2032 on account of the strong presence of several market participants to focus on the development of innovative products for better patient management.

Abbott Laboratories, BAG Healthcare Ltd., Beckman Coulter, Inc., Bio Rad Laboratories, BioSystems, Boule Diagnostics, Danaher Corporation, Diatron, F. Hoffmann-La Roche Ltd., HemoCue AB, HORIBA, and Mindray are some major hematology diagnostics business players.